UK doctors want to screen embryos for breast and bowel cancer
UK scientists are soon to apply for a licence to screen IVF embryos for breast and bowel cancer genes so that parents will not place their children at risk of suffering from these diseases in later life. “The whole idea is to select the embryo that doesn’t have the gene so the woman can start their pregnancy knowing the baby is safe,” said Dr Paul Serhal, of University College London Hospital.
The idea was immediately savaged by Josephine Quintavalle, of Comment on Reproductive Ethics. “By the time these embryos have reached the age when they are at risk of breast cancer, medical science will have advanced 30 years and we may even have a cure,” she said. “What we are doing here is getting away from the concept of curing disease and towards eliminating the person with the disease.”
Dr Serhal responded that “I disagree with Mickey Mouse people saying it is meddling with nature. It is simply a selection process to try to get rid of these genetic diseases.”
- Prescribe morning-after pills to young teenagers, say US pediatric group - November 30, 2012
- Bahrain sentences protest docs to prison - November 28, 2012
- Terry Pratchett assisted suicide documentary wins International Emmy - November 27, 2012
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...